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In May 2008, a 21-year-old single, non-obese, 
diabetic lady was referred to our clinic for 
routine eye examinations. The patient had been 
diagnosed with diabetes mellitus three months 
earlier and was receiving 100 milligrams of 
metformin daily and 80 milligrams of gliclazide 
twice daily orally, consistently maintaining her 
blood glucose levels between 72-90 mg/dl. She 
had a positive family history of diabetes mellitus. 
No related comorbidities were reported in her 
nephrology and rheumatology consultations and 
she had no visual complaints such as floaters, 
blurred vision, metamorphopsia or photophobia. 
 Ocular examination revealed bilateral 
best corrected visual acuity (BCVA) of 6/18, 
and normal anterior segments without 
neovascularization on the iris or in the angles. 
However, fundus examination showed florid 
neovascularization of the disc (NVD) in both 
eyes (Fig.1). The vessels were profuse and 
extended all around the discs. The condition was 
termed “coralliform” NVD for its resemblance 
to sea corals. Other areas of neovascularization 
(NVE) were also seen in both eyes. The macular 
region was edematous bilaterally with a few 
hard exudates. Optical coherence tomography 
confirmed the presence of macular edema (Fig.2). 
The condition was explained to the 
patient and informed consent was obtained 
for bilateral panretinal laser photocoagulation 
(PRP) and grid laser photocoagulation. An 
initial grid laser treatment followed by multiple 
sessions of PRP was performed in both eyes 
(Fig.3). Despite two sessions of grid laser, the 
macular edema persisted. She refused receiving 
intraocular injections, therefore bilateral orbital 
floor injections of triamcinolone acetonide (20 
milligrams) were administered twice within a 
one month interval. Subsequently, the macular 
edema resolved.
The last examination in March 2011 revealed 
BCVA of 6/10 in both eyes and significant 
regression of NVD and NVE. There was no 
macular edema (Fig.4) and the patient was 
satisfied with her vision.
DISCUSSION 
Florid diabetic retinopathy (FDR) is characterized 
by proliferative diabetic retinopathy in a young 
patient, with predilection for females, bilateral 
affliction and a rapid course which may lead to 
blindness in a short time. The condition is usually 
exacerbated by poor metabolic control. This 
Figure 1. Coralliform NVD in the right eye at initial presentation (left image); NVD and macular edema in the left eye 
at initial presentation (right image).Photo Essay; Ahmad and Ghani
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condition is assumed to be secondary to acute 
ischemia. High blood levels of growth hormone 
have also been implicated in its causation. An 
important pathophysiologic mechanism appears 
to be diffuse retinal ischemia with widespread 
blood-retinal barrier breakdown.1 It has been 
postulated that acute hypoglycemic episodes 
together with transient increases in serum 
levels of insulin-like growth factor 1 (IGF-1) and 
vitreous levels of vascular endothelial growth 
factor (VEGF) contribute to the development of 
FDR.2 Despite improved management techniques, 
the prognosis of FDR remains guarded. Seyer-
Hansen3 reported a 22-year-old man who 
developed total blindness within 30 months 
of the diagnosis of diabetes mellitus. In a long 
term study on FDR by Lettanzio1, patients 
were categorized into two groups according 
to baseline retinal condition: group 1 included 
eyes amenable to laser photocoagulation and 
when necessary, to subsequent vitreoretinal 
surgery; whereas group 2 eyes consisted of 
eyes with more advanced diabetic retinopathy, 
directly undergoing vitreoretinal surgery and 
laser photocoagulation. The patients were 
followed for 54 months; 75% of eyes in group 1 
had a favorable anatomical outcome with mean 
final visual acuity of 0.47. In group 2, diabetic 
retinopathy progressed in 68% of eyes and mean 
final visual acuity was 0.14. The latter group had 
6 times higher rates of blindness as compared to 
group 1 (31% versus 5%). The authors concluded 
that early diagnosis and treatment can halt the 
progression of FDR in three out of four cases.
Kohner et al4 reported a group of 34 patients 
with FDR. The patients were divided into no 
treatment, PRP, or pituitary ablation. After one 
year, of the 11 eyes which had undergone PRP, 6 
Figure 4. Fundus appearance in the right (left image) and left eye (right image) at final follow-up.
Figure 3. Right eye after laser photocoagulation (left image); left eye after initiation of laser photocoagulation (right 
image).Photo Essay; Ahmad and Ghani
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were blind while 5 had good vision; by the end of 
the second year, only 3 eyes had good vision and 
the rest were blind. Out of a total of 20 patients 
who underwent pituitary ablation, at the end of 
the first year only 3 eyes were blind, while after 
5 years 12 of 17 eyes could still see and only 2 
more had become blind. The authors claimed that 
in this rare form of retinopathy, pituitary ablation 
remains the treatment of choice if vision is to be 
maintained. Valone and McMeel5 also reported 
better vision preservation in patients undergoing 
pituitary ablation, as compared to untreated 
subjects. An earlier report on 9 patients treated 
with pituitary ablation or laser photocoagulation 
noted regression of FDR in both groups.6 FDR was 
also reported to regress with an insulin-infusion 
device7 and also with continuous subcutaneous 
insulin infusion8. Casati et al9 reported a 17-year-
old girl with Donahue syndrome and FDR. Her 
5 year follow up after PRP revealed satisfactory 
regression of NVD and maintenance of good 
visual acuity. Nevertheless, diabetic retinopathy 
has been known to deteriorate rapidly after 
institution of strict metabolic control.10,11
The patient described herein is a typical case 
of FDR; a 21-year-old diabetic lady with severe 
bilateral proliferative diabetic retinopathy at 
presentation. She demonstrated a favorable 
response to aggressive PRP. The macular edema 
also resolved with a judicious combination of 
grid laser photocoagulation and orbital floor 
triamcinolone acetonide injection. Bandello 
et al12 have reported a case of FDR, where 
intravitreal triamcinolone acetonide (IVTA) 
followed by PRP was done for one eye and the 
other eye underwent PRP alone. The authors 
reported greater reduction in retinal thickening 
and fluorescein leakage from retinal new vessels 
in the eye which had been given IVTA.
In summary, FDR is an aggressive presentation 
of diabetic retinopathy; therefore all young 
diabetics should be screened as soon as possible. 
These patients need to be closely monitored to 
identify the condition at its inception. Once 
FDR develops, the patient needs to be treated 
aggressively with laser photocoagulation and 
possibly vitrectomy. However, FDR still remains 
an unfortunate presentation in young diabetics 
and portends a guarded prognosis.
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